May 15 (Reuters)-
Sundrug Co Ltd
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Mar 31, 2023 Mar 31, 2022 Mar 31, 2024 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 690.46 648.73 746.50 368.20
(+6.4 pct) (+2.3 pct) (+8.1 pct) (+8.5 pct)
Operating 37.45 34.05 38.40 18.70
(+10.0 pct) (-8.8 pct) (+2.5 pct) (+1.0 pct)
Recurring 38.13 34.73 39.00 19.00
(+9.8 pct) (-9.1 pct) (+2.3 pct) (+1.2 pct)
Net
Net 25.70 23.85 26.30 13.10
(+7.8 pct) (-5.8 pct) (+2.3 pct) (+3.0 pct)
EPS 219.83 yen 204.02 yen 224.93 yen 112.04 yen
EPS Diluted 219.82 yen 204.01 yen
Ann Div 100.00 yen 71.00 yen 114.00 yen
-Q2 Div 50.00 yen 35.00 yen 57.00 yen
-Q4 Div 50.00 yen 36.00 yen 57.00 yen
NOTE - Sundrug Co Ltd.
*Second Net profit row denotes profit attributable to owners ofthe parent
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=9989.T